BiotechTube

Axatilimab

Phase 2Recruiting
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Idiopathic Pulmonary Fibrosis

Conditions

Idiopathic Pulmonary Fibrosis

Trial Timeline

Dec 11, 2023 → Nov 1, 2026

NCT ID
NCT06132256

About Axatilimab

Axatilimab is a phase 2 stage product being developed by Syndax Pharmaceuticals for Idiopathic Pulmonary Fibrosis. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06132256. Target conditions include Idiopathic Pulmonary Fibrosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (3)

NCT IDPhaseStatus
NCT06132256Phase 2Recruiting
NCT04710576Phase 2Active
NCT03604692Phase 1/2Completed

Competing Products

20 competing products in Idiopathic Pulmonary Fibrosis

See all competitors
ProductCompanyStageHype Score
KPL-716 + PlaceboKiniksa PharmaceuticalsPhase 2
47
Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) + PlaceboRein TherapeuticsPhase 1
25
LTI-03 + PlaceboRein TherapeuticsPhase 1
25
LTI-03 + PlaceboRein TherapeuticsPhase 2
44
Tirzepatide + Tirzepatide PlaceboEli LillyApproved
85
MRA(Tocilizumab)Chugai PharmaceuticalPhase 3
77
MRA(Tocilizumab) + placeboChugai PharmaceuticalPhase 3
77
MRA(Tocilizumab)Chugai PharmaceuticalPhase 3
77
MRA(Tocilizumab)Chugai PharmaceuticalPhase 3
77
Zimura + EyleaAstellas PharmaPhase 2
52
Avacincaptad PegolAstellas PharmaPhase 2
52
Rituximab + cyclosporineSun PharmaceuticalPhase 3
77
E5501EisaiPhase 1
33
E5501 + Drug: E5501EisaiPhase 1
33
E5501 40 mg 2 x 20-mg tablets, orally, fasted + E5501 40 mg 2 x 20-mg tablets, orally, with food + E5501 40mg 2 x 20-mg tablets, orally, fasted + E5501 40 mg 2 x 20-mg tablets, orally, with foodEisaiPhase 1
33
Eltrombopag + Avatrombopag + Standard of careEisaiPhase 3
77
Placebo + Avatrombopag tabletsEisaiPhase 2
52
PerampanelEisaiPre-clinical
23
Blinded (placebo) + Open Label (Avatrombopag tablets) + Blinded (Avatrombopoag tablets)EisaiPhase 2
52
Istradefylline 20 mg or 40 mgKyowa KirinPhase 3
77

Other Products from Syndax Pharmaceuticals

Revumenib + Placebo + Intensive Chemotherapy RegimenPhase 3
72
entinostat + anastrozolePhase 2
47
EntinostatPhase 2
47
SNDX-6352 + PlaceboPhase 2
47
Entinostat + ErlotinibPhase 2
47